STEMGEN

StemGen is a clinical stage biotech company developing innovative differentiation biotherapies for cancer... StemGen was created in 2006 and engaged in the research and development of innovative oncological therapies, for improving the lives of people with gliomas and glioblastomas. The Company, which was built upon the knowledge and expertise of a world-class research team led by renowned neuroscientist Prof. Angelo Vescovi, is a drug discovery and development company... Particular emphasis had originally been put on the study of incurable brain cancers, namely glioblastomas. More recently, StemGen's activity has rapidly and successfully expanded to impact on colorectal carcinomas.

Also known as: STEMGEN S.p.A.

VAT numbers: 05041640961